National Survey on Infiltrative Breast Cancer (CSI)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00696527
First received: June 10, 2008
Last updated: December 9, 2010
Last verified: December 2010
  Purpose

The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.


Condition
Infiltrative Breast Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Radiological, Clinical and Histological characteristics [ Time Frame: Once ]

Secondary Outcome Measures:
  • Treatments: Surgery, radiotherapy, chemotherapy, hormonotherapy. [ Time Frame: Once ]

Estimated Enrollment: 1500
Study Start Date: June 2007
Study Completion Date: July 2008
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

First ten consecutive women with infiltrative breast cancer seen by oncologists, and fulfilling eligibility criteria.

Criteria

Inclusion Criteria:

  • Women> or = 18 years old
  • Women with newly diagnosis of infiltrative breast cancer
  • Agree to take part in this study

Exclusion Criteria:

  • Women with other malignant tumor (except in situ cervical carcinoma or treated basal cell carcinoma)
  • Women with in situ ductal carcinoma or in situ lobular carcinoma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00696527

  Hide Study Locations
Locations
France
Research Site
Aix En Provence, France
Research Site
Aix En Provence Cedex 1, France
Research Site
Ales Cedex, France
Research Site
Amilly, France
Research Site
Angers Cedex 01, France
Research Site
Annecy, France
Research Site
Annecy Cedex, France
Research Site
Arpajon Cedex, France
Research Site
Arras, France
Research Site
Aubervilliers Cedex, France
Research Site
Aulnay Sous Bois Cedex, France
Research Site
Auxerre Cedex, France
Research Site
Avignon, France
Research Site
Avignon Cedex 2, France
Research Site
Beaune Cedex, France
Research Site
Besancon, France
Research Site
Beziers, France
Research Site
Bleriot, France
Research Site
Bordeaux, France
Research Site
Bordeaux Cedex, France
Research Site
Bourg En Bresse Cedex, France
Research Site
Brest Cedex 2, France
Research Site
Bruay La Buissiere Cedex, France
Research Site
Bruges Cedex, France
Research Site
Caen Cedex 4, France
Research Site
Caen Cedex 5, France
Research Site
Carcassonne, France
Research Site
Castelnau Le Lez Cedex, France
Research Site
Chalon Sur Saone, France
Research Site
Chambery, France
Research Site
Chambery Cedex, France
Research Site
Chartre, France
Research Site
Cherbourg Octeville Cedex, France
Research Site
Clermont Ferrand Cedex 1, France
Research Site
Colmar, France
Research Site
Colmar Cedex, France
Research Site
Colombes Cedex, France
Research Site
Coudekerque Branche Cedex, France
Research Site
Creteil Cedex, France
Research Site
Croix, France
Research Site
Cucq, France
Research Site
Dax Cedex, France
Research Site
Dijon Cedex, France
Research Site
Evreux, France
Research Site
Grasse Cedex, France
Research Site
Grenoble Cedex 2, France
Research Site
Guilherand Granges, France
Research Site
Hyeres, France
Research Site
La Chaussee St Victor, France
Research Site
La Garenne Colombes, France
Research Site
La Seyne Sur Mer, France
Research Site
La Tronche, France
Research Site
Lagny Sur Marne Cedex, France
Research Site
Le Chesnay Cedex, France
Research Site
Le Mans Cedex 2, France
Research Site
Lens Cedex, France
Research Site
Levallois Perret Cedex, France
Research Site
Libourne Cedex, France
Research Site
Lille, France
Research Site
Lille Cedex, France
Research Site
Limoges, France
Research Site
Limoges Cedex 1, France
Research Site
Loos, France
Research Site
Lorient Cedex, France
Research Site
Lormont, France
Research Site
Lyon, France
Research Site
Lyon Cedex 03, France
Research Site
Lyon Cedex 04, France
Research Site
Lyon Cedex 08, France
Research Site
Lyon Cedex 09, France
Research Site
Mantes La Jolie Cedex, France
Research Site
Mareuil Les Meaux, France
Research Site
Marseille, France
Research Site
Marseille Cedex 06, France
Research Site
Marseille Cedex 09, France
Research Site
Marseille Cedex 12, France
Research Site
Meudon La Foret, France
Research Site
Mont de Marsan Cedex, France
Research Site
Montmorency, France
Research Site
Montpellier, France
Research Site
Montpellier Cedex 5, France
Research Site
Mulhouse Cedex 1, France
Research Site
Nancy, France
Research Site
Nantes, France
Research Site
Neuilly Sur Seine, France
Research Site
Nice, France
Research Site
Nice Cedex 2, France
Research Site
Nimes, France
Research Site
Orleans Cedex 1, France
Research Site
Paris, France
Research Site
Paris Cedex 04, France
Research Site
Paris Cedex 05, France
Research Site
Paris Cedex 10, France
Research Site
Paris Cedex 15, France
Research Site
Paris Cedex 20, France
Research Site
Pessac, France
Research Site
Pierre Benite Cedex, France
Research Site
Ploemeur, France
Research Site
Poissy Cedex, France
Research Site
Quimper Cedex, France
Research Site
Reims, France
Research Site
Reims Cedex, France
Research Site
Rennes Cedex, France
Research Site
Roanne Cedex, France
Research Site
Rodez Cedex 9, France
Research Site
Rouen, France
Research Site
Rouen Cedex, France
Research Site
Saint Mandee, France
Research Site
Saintes Cedex, France
Research Site
Sarcelle, France
Research Site
Sarcelles, France
Research Site
St Benoit La Foret, France
Research Site
St Brieuc Cedex 1, France
Research Site
St Cloud, France
Research Site
St Herblain, France
Research Site
St Herblain Cedex, France
Research Site
St Jean, France
Research Site
St Martin Des Champs, France
Research Site
St Maur Des Fosses, France
Research Site
St Michel, France
Research Site
St Nazaire, France
Research Site
St Priest En Jarez Cedex, France
Research Site
Strasbourg, France
Research Site
Thionville Cedex, France
Research Site
Toulon, France
Research Site
Toulon Cedex, France
Research Site
Toulouse, France
Research Site
Toulouse Cedex 3, France
Research Site
TOURS cedex 2, France
Research Site
Tours Cedex 9, France
Research Site
Troyes Cedex, France
Research Site
Valence, France
Research Site
Valenciennes Cedex, France
Research Site
Vandoeuvre Les Nancy Cedex, France
Research Site
Vichy Cedex, France
Research Site
Villejuif Cedex, France
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Alain Castaigne, Medical Director AstraZeneca
  More Information

No publications provided

Responsible Party: Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00696527     History of Changes
Other Study ID Numbers: NIS-OFR-DUM-2007/1
Study First Received: June 10, 2008
Last Updated: December 9, 2010
Health Authority: France: French Data Protection Authority

Keywords provided by AstraZeneca:
Infiltrative breast cancer-Clinical practice
Women with infiltrative breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on August 26, 2014